Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens

Journal of General Virology

Volumn 78, Issue 2, 1997, Pages 427-434

  Karem, Kevin L ^a,b   Bowen, JoAnne ^a   Kuklin, Nelly ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HERPES VACCINE; IMMEDIATE EARLY PROTEIN; IMMUNOGLOBULIN A; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FECES ANALYSIS; HERPES SIMPLEX VIRUS 1; HERPES ZOSTER; HUMORAL IMMUNITY; IMMUNIZATION; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR CLONING; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMID; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; VIRUS RECOMBINANT;

ANIMALIA; HERPES; HERPES ZOSTER; HUMAN HERPESVIRUS 1; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0031028321     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-2-427     Document Type: Article

References (41)

1. Aliabadi, Z., Park, Y. K., Slonczewski, J. L. & Foster, J. W. (1988). Novel regulatory loci controlling oxygen and pH-regulated gene expression in Salmonella typhimurium. Journal of Bacteriology 70, 842-851.
2. Banks, T. A., Allen, E. M., Dasgupta, S., Sandri-Golden, R. & Rouse, B. T. (1991). Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate early protein ICP27. Journal of Virology 65, 3185-3191.
3. Banks, T. A., Nair, S. & Rouse, B. T. (1992). Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate early protein ICP27 of Herpes simplex virus. Journal of Virology 67, 613-616.
4. Bowen, J. C., Alpar, O., Phillpotts, R., Roberts, I. S. & Brown, M. R. W. (1990). Preliminary studies on infection by attenuated Salmonella in guinea-pigs and on expression of herpes simplex virus. Research in Microbiology 141, 873-877.
5. Brown, A., Hormaeche, C. E., Demarco de Hormaeche, R., Winther, M., Dougan, G., Maskell, D. J. & Stocker, B. A. D. (1987). An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned β-galactosidase in mice. Journal of Infectious Diseases 155, 86-91.
6. Burke, R. L. (1991). Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use. Reviews of Infectious Diseases 13(Suppl. 11), S906.
7. Burke, R. L. (1992). Contemporary approaches to vaccination against HSV. In Current Topics in Microbiology and Immunology. 179, 137.
8. Cárdenas, L. & Clements, J. D. (1992). Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clinical Microbiology Reviews. 5, 328-342.
9. Chabalgoity, J. A., Khan, C. M. A., Nash, A. A. & Hormaeche, C. E. (1996). A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Molecular Microbiology 19, 791-801.
10. Challacombe, S. J. & Tomasi, T. B., Jr (1980). Systemic tolerance and secretory immunity after oral immunization. Journal of Experimental Medicine 152, 1459-1472.
11. Chatfield, S. N., Dougan, G. & Roberts, M. (1994). Progress in the development of multivalent oral vaccines based on live attenuated Salmonella. In Modern Vaccinology, pp. 55-86. Edited by E. Kurstak. New York: Plenum Medical.
12. Chatfield, S. N., Charles, I. G., Makoff, A. J., Oxer, M. D., Dougan, G., Pickard, D., Slater, D. & Fairweather, N. F. (1992). Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains : development of a single-dose oral tetanus vaccine. Bio/Technology 10, 888-892.
13. Cher, D. J. & Mosmann, T. R. (1987). Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th-1 clones. Journal of Immunology 138, 3688-3694.
14. Curtiss, R., III & Kelly, S. M. (1987). Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infection and Immunity 55, 3035-3043.
15. Davis, R. W., Botstein, D. & Roth, J. R. (1980). A Manual for Genetic Engineering. Advanced Bacterial Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
16. Denich, K., Borlin P., O'Hanley, P. D., Howard, M. & Heath, A. W. (1993). Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium : persistence and immune response in BALB/c mice and susceptibility to macrophage killing. Injection and Immunity 61, 4818-4827.
17. + cytotoxic T lymphocytes specific for herpes simplex virus-1: implications for the development of herpetic stromal keratitis in mice. Clinical Immunology and Immunopathology, 398-409.
18. Fayolle, C., O'Callaghan, D., Martineau, P., Charbit, A., Clement, J. M., Hofnung, M. & LeClerc, C. (1994). Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium. Infection and Immunity 62, 4310-4319.
19. Flynn, J. L., Weiss, W. R., Norris, K. A., Seifert, H. S., Kumar, S. & So, M. (1990). Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivering system. Molecular Microbiology 4, 2111-2118.
20. Fouts, T. R., Tuskan, R. G., Chada, S., Hone, D. M. & Lewis, G. K. (1996). Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120. Vaccine 13, 1697-1705.
21. Hess, J., Gentschev, I., Miko, D., Welzel, M., Ladel, C., Goebel, W. & Kaufmann, S. H. E. (1996). Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proceedings of the National Academy of Sciences, USA 93, 1458-1463.
22. Holley, E. A. & Foster, J. W. (1982). Bacteriophage P22 as a vector for Mu mutagenesis in Salmonella typhimuirium: isolation of nad-lac and pnc-lac gene fusions. Journal of Bacteriology 158, 959-962.
23. Ianaro, A., Xu, D., O'Donnell, C. A., Di Rosa, M. & Liew, F. Y. (1995). Expression of TGF-β in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammatin, IL-2 and IFN-γ, but enhancement of IL-10, in carrageenin-induced oedema in mice. Immunology 84, 8-15.
24. Irie, H., Harada, Y., Kataoka, M., Nagamuta, M., Moriya, Y., Saito, M., Matsubara, S., Kojima, K. & Sugawara, Y. (1992). Efficacy of oral administration of live herpes simplex virus type-1 as a vaccine. Journal of Virology 66, 2428-2434.
25. Karem, K. L., Chatfield, S., Kuklin, N. & Rouse, B. T. (1995). Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infection and Immunity 63, 4557-4563.
26. Karem, K. L., Kanangat, S. & Rouse, B. T. (1996). Cytokine expression in the gut associated lymphoid tissue (G. A. L. T.) after oral administration of attenuated Salmonella vaccine strains. Vaccine (in press).
27. Manickan, E., Yu, Z., Rouse, R. J. D., Wire, W. S. & Rouse, B. T. (1995a). Induction of protective immunity against herpes simplex virus with DNA encoding the intermediate early protein ICP27. Viral Immunology 8, 53-61.
28. + T cells. Journal of Virology 69, 4711-4716.
29. Martin, S. & Rouse, B. T. (1987). The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection. Journal of Immunology 138, 3431-3437.
30. Martin, S., Zhu, X., Silverstein, S. J., Courtney, R. J., Yao, F., Jenkins, F. J. & Rouse, B. T. (1990). Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0. Journal of General Virology 71, 2391-2399.
31. Mester, J. C., Glorioso, J. C. & Rouse, B. T. (1991). Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies. Journal of Infectious Diseases 163, 263-269.
32. Nahmias, A. J. & Josey, W. E. (1968). Antigenic and biologic differences in herpesvirus. Progress in Medical Virology 10, 110.
33. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6, 693-697.
34. + T-cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. Journal of General Virology 68, 825-833.
35. Richman, L. K. (1979). Immunological unresponsiveness after enteric administration of protein antigens. In Immunology of Breast Milk, pp. 49-62. Edited by P. L. Ogra & D. Dayton. New York: Raven Press.
36. Roberts, M., Chatfield, S. N. & Dougan, G. (1994). Salmonella as carriers of heterologous antigens. In Novel Delivery Systems for Oral Vaccines, pp. 27-58. Edited by D. T. O'Hagan. Boca Raton, Fla, CRC Press.
37. Rouse, B. T., Norley, S. & Martin, S. (1988). Antiviral cytotoxic T lymphocyte induction and vaccination. Reviews of Infectious Diseases. 10, 16-33.
38. Simmons, A. & Nash, A. A. (1984). Zosteriform spread of HSV as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. Journal of Virology 52, 816-821.
39. Simmons, A. & Tscharke, D. C. (1992). Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. Journal of Experimental Medicine 175, 1337-1344.
40. Smith, P. M., Wolcott, R. M., Chervenak, R. & Jennings, S. R. (1994). Control of acute cutaneous herpes simplex virus infection: T-cell mediated viral clearance is dependant upon interferon-gamma. Virology 202, 76-88.
41. Weiner, H. L., (1994). Oral tolerance. Proceedings of the National Academy of Sciences, USA 91, 10762-10765.